Veradermics, Inc. (MANE)
102.23
+3.77
(+3.83%)
USD |
NYSE |
Aug 25, 16:00
102.23
0.00 (0.00%)
After-Hours: 16:08
Veradermics EPS Diluted (Quarterly) : -0.5625 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5625 |
| March 31, 2026 | -0.8037 |
| December 31, 2025 | -0.7554 |
| Date | Value |
|---|---|
| June 30, 2025 | -0.4824 |
| March 31, 2025 | -0.3905 |
| December 31, 2024 | -0.1846 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.939 |
| EyePoint, Inc. | -1.092 |
| Elanco Animal Health, Inc. | 0.1067 |
| Tarsus Pharmaceuticals, Inc. | -0.4275 |
| Amylyx Pharmaceuticals, Inc. | -0.3905 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.50M |
| Total Expenses (Quarterly) | 23.50M |
| Enterprise Value | 3.294B |
| Earnings Yield | -2.55% |
| Normalized Earnings Yield | -2.547 |